The diabetes-atrial fibrillation paradox

Eugene S J Tan¹, Wan Ting Tay², Tiew-Hwa Katherine Teng², Arthur Mark Richards^{1

3

4}, Robert N Doughty⁵, Carolyn S P Lam^{2

6

7

8}

Affiliations

¹ National University Heart Centre, Singapore.
² National Heart Centre Singapore, Singapore.
³ Christchurch Heart Institute, University of Otago, New Zealand.
⁴ Cardiovascular Research Institute, National University Health System, Singapore.
⁵ Heart Health Research Group, University of Auckland, New Zealand.
⁶ Duke-NUS Graduate Medical School, Singapore.
⁷ University Medical Centre Groningen, Netherlands.
⁸ The George Institute for Global Health, Australia.

Comment

Eugene S J Tan et al. Heart. 2019 Jun.

. 2019 Jun;105(11):893.

doi: 10.1136/heartjnl-2019-315018.

Eugene S J Tan¹, Wan Ting Tay², Tiew-Hwa Katherine Teng², Arthur Mark Richards^{1

3

4}, Robert N Doughty⁵, Carolyn S P Lam^{2

6

7

8}

¹ National University Heart Centre, Singapore.
² National Heart Centre Singapore, Singapore.
³ Christchurch Heart Institute, University of Otago, New Zealand.
⁴ Cardiovascular Research Institute, National University Health System, Singapore.
⁵ Heart Health Research Group, University of Auckland, New Zealand.
⁶ Duke-NUS Graduate Medical School, Singapore.
⁷ University Medical Centre Groningen, Netherlands.
⁸ The George Institute for Global Health, Australia.

No abstract available

Keywords: atrial fibrillation; diabetes; heart failure.

Conflict of interest statement

Competing interests: None declared.

Ethnicity, heart failure, atrial fibrillation and diabetes: collider bias.
Burden AF, Timpson N. Burden AF, et al. Heart. 2019 Jun;105(11):814-816. doi: 10.1136/heartjnl-2018-314467. Epub 2019 Feb 6. Heart. 2019. PMID: 30728157 No abstract available.